| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/06/2006 | US20060074021 polymer of positively charged amino acid residues and at least one omega -amino-fatty acid residue; stable, non-toxic and avoiding development of resistance |
| 04/06/2006 | US20060074018 Methods of diagnosing & treating diabetes and insulin resistance |
| 04/06/2006 | US20060074016 have effectors with individually distinct biological functions and corresponding activator sites that can each initiate or amplify the biological function of effectors upon context-activation; useful in the diagnosis, prophylaxis, and therapy; minimizing cytotoxicity and drug/antibiotic resistance |
| 04/06/2006 | US20060074010 Method and apparatus for purifying pharmaceutical compositions using supercritical fluids |
| 04/06/2006 | US20060074009 Natriuretic compounds, conjugates, and uses thereof |
| 04/06/2006 | US20060074008 monoclonal antibody conjugated with peptide drug such as dolastatin derivative |
| 04/06/2006 | US20060074007 Unique dendritic cell-associated C-type lectins, dectin-1 and dectin-2; compositions and uses thereof |
| 04/06/2006 | US20060073586 A N-terminal domain, five or six rod repeats, H1 and H4 domains of a dystrophin protein, and a cysteine-rich domain; Duchenne and Becker muscular dystrophies |
| 04/06/2006 | US20060073579 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073576 envelope proteins (Env) comprising CD4 (and mimetics) binding site and deletion region; maintains structural conformation of complementary determining region 2-like loop; insertion near chemokine receptor binding site; vectors, cells; liposomes |
| 04/06/2006 | US20060073574 Engineered biosynthesis of novel polyenes |
| 04/06/2006 | US20060073573 Chemotactic cytokine III |
| 04/06/2006 | US20060073572 Cytokine structurally related to IL-17 |
| 04/06/2006 | US20060073571 Recombinant bifunctional protein of human lutropin receptor and human chorionic gonadotropin B-subunit and uses thereof |
| 04/06/2006 | US20060073570 Apo-2 receptor |
| 04/06/2006 | US20060073568 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073567 Novel insulin/IGF/relaxin family polypeptides and DNAs thereof |
| 04/06/2006 | US20060073566 Active modified hedgehog proteins |
| 04/06/2006 | US20060073565 Novel nucleic acid molecules encoding opioid growth factor receptors |
| 04/06/2006 | US20060073564 Nucleic acid molecule encoding a (poly)peptide co-segregating in mutated form with Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED) |
| 04/06/2006 | US20060073563 Erythropoietin derivatives with altered immunogenicity |
| 04/06/2006 | US20060073562 Screening and identifying compounds compounds that will modulate the interaction of protein tyrosine kinase substrates with their intracellular ligands, as well as between their intracellular ligands and other members of the signaling pathway. |
| 04/06/2006 | US20060073561 157 human secreted proteins |
| 04/06/2006 | US20060073559 Ehanced protein expression in bacillus |
| 04/06/2006 | US20060073558 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073557 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073556 polypeptide that is an epitope tag or a Fc region of an immunoglobulin; used in modulating cell proliferation, inducing neovascularization and diagnosis of tumors |
| 04/06/2006 | US20060073555 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073554 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073553 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073552 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073551 Pro4487 polypeptides |
| 04/06/2006 | US20060073550 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073549 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073548 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073547 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073546 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073545 PRO polypeptides and chimeric polypeptides; may be drug target for tumors |
| 04/06/2006 | US20060073544 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073543 Process for the preparation of angiotensis converting enzyme (ACE) inhibitors and its use |
| 04/06/2006 | US20060073535 Methods and kits for measuring ADAMTS13/FXI complexes |
| 04/06/2006 | US20060073522 Derived from ghrelin polypeptide, labelled with fluorochrome and cysteine; drug screening; high throughput assay |
| 04/06/2006 | US20060073516 Novel screening method |
| 04/06/2006 | US20060073515 Human polypeptide receptors for lysophospholipids and sphingolipids and nucleic acids encoding the same |
| 04/06/2006 | US20060073514 Anticarcinogenic, antiproliferative agents; drug screening, receptor binding assay |
| 04/06/2006 | US20060073497 Isolated polypeptide from a macrophage, inflammatory cell, liver cell, hepatocyte, intestinal cell, hematopoietic cell, pancreatic cell, skeletal muscle cell, nervous system; modulation of iron transport across a cell membrane; regulate diseases of iron metabolism |
| 04/06/2006 | US20060073478 Atlastin |
| 04/06/2006 | US20060073476 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
| 04/06/2006 | US20060073468 Genetically modified cyclic-nucleotide controlled ion channels and the use thereof |
| 04/06/2006 | US20060073169 Acellular antibordetella vaccine |
| 04/06/2006 | US20060073165 Vaccine against infectious agents having an intracellular phase, composition for the treatment and prevention of HIV infections, antibodies and method of diagnosis |
| 04/06/2006 | US20060073164 Dengue and West Nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications |
| 04/06/2006 | US20060073163 Anti-sepsis conjugate vaccine |
| 04/06/2006 | US20060073162 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor |
| 04/06/2006 | US20060073161 Nucleic acid and amino acid sequences relating to Bacteroides fragilis for diagnostics and therapeutics |
| 04/06/2006 | US20060073160 Cloning of chicken anemia virus DNA |
| 04/06/2006 | US20060073158 Methods and compositions comprising supramolecular constructs |
| 04/06/2006 | US20060073157 Attenuated live Neospora vaccine |
| 04/06/2006 | US20060073155 Methods and compositions for diseases associated with amyloidosis |
| 04/06/2006 | US20060073154 Group a streptococci bind to mucin and human pharyngeal cells through a sialic acid-containing receptor |
| 04/06/2006 | US20060073150 monoclonal antibodies or antigen binding fragments that specifically to six transmembrane epithelial antigens of the prostate (STEAP-1), used for medical diagnosis, prognosis, prophylaxis and/or therapy for cancers |
| 04/06/2006 | US20060073146 Uses of agonists and antagonists to modulate activity of TNF-related molecules |
| 04/06/2006 | US20060073140 Dual-specificity antibody having specificity for both an activated erbB2 receptor and erbB1 dimers, without significant affinity for monomeric EGFr that is not activate; specificity of the antibodies is due to their recognition and binding of activation epitopes; diagnosis, imaging and for treating tumor |
| 04/06/2006 | US20060073138 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 04/06/2006 | US20060073137 Humanised antibodies |
| 04/06/2006 | US20060073136 Humanised antibodies |
| 04/06/2006 | US20060073135 Methods and compositions for modulating and detecting wisp activity |
| 04/06/2006 | US20060073134 Determining in a pancreas sample the level of expression of a marker protein; islet cell regeneration factor; lithostathine 1 alpha, leukocyte elastase inhibitor, lipocalin-2; indicates diabetes |
| 04/06/2006 | US20060073128 Means and methods for the modulation of arteriogenesis |
| 04/06/2006 | US20060073125 Isolation and use of solid tumor stem cells |
| 04/06/2006 | US20060073123 Adenovirus vectors for immunotherapy |
| 04/06/2006 | US20060073115 Autoimmune diseases, graft rejections, chronic inflammations, sepsis, ischemia and reperfusion syndrome and atherosclerosis, inflamamatory disorders or infection by microorganisms |
| 04/06/2006 | US20060073114 Compounds and methods to inhibit or augment an inflammatory response |
| 04/06/2006 | US20060073111 Method for identifying shampoo-resistant hair-binding peptides and hair benefit agents therefrom |
| 04/06/2006 | DE102004054545A1 Änderung des Beladungszustandes von MHC-Molekülen Changing the load state of MHC molecules |
| 04/06/2006 | DE102004047269A1 New protein or peptide involved in biosynthesis of lysolipins, useful for preparing lysolipin antibiotics in transformed cells |
| 04/06/2006 | DE102004046616A1 Active pharmaceutical ingredient for the treatment of hospital acquired infection with selected nucleic acid sequence |
| 04/06/2006 | DE102004046540A1 Annexin-Modulation und Infektionsresistenz Annexin-modulation and resistance to infection |
| 04/06/2006 | CA2848573A1 Rnai modulation of apob and uses thereof |
| 04/06/2006 | CA2585507A1 Recombinant bifunctional protein of human lutropin receptor and human chorionic gonadotropin b-subunit and uses thereof |
| 04/06/2006 | CA2582940A1 Myostatin isoform |
| 04/06/2006 | CA2581966A1 Group a streptococcus crge protein |
| 04/06/2006 | CA2581840A1 Optimized vaccines to provide protection against ebola and other viruses |
| 04/06/2006 | CA2581469A1 Interleukin-9 and interleukin-4 chimeric antagonist muteins and methods of using same |
| 04/06/2006 | CA2579971A1 A bacterial atp synthase binding domain |
| 04/06/2006 | CA2554718A1 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis |
| 04/05/2006 | EP1643252A2 Peptides for discrimination of prions |
| 04/05/2006 | EP1642987A2 Nucleotide sequences derived from the genomes of the retroviruses HIV-1, HIV-2 and SIV, and their application to the amplification of these viral genomes and to the in vitro diagnosis of infections resulting from these viruses |
| 04/05/2006 | EP1642980A1 Modified proteins and methods of their production |
| 04/05/2006 | EP1642977A1 Gene participating in growth promoting function of acetic acid bacterium and utilization of the same |
| 04/05/2006 | EP1642975A2 Chemokine receptors 88-2B (CKR-3) and their antibodies |
| 04/05/2006 | EP1642974A1 Recombinant soluble Fc receptors |
| 04/05/2006 | EP1642973A1 Therapeutic uses of BR43X2 soluble receptors |
| 04/05/2006 | EP1642972A1 Therapeutic uses of BR43X2 soluble receptors |
| 04/05/2006 | EP1642971A1 Fucose transporter |
| 04/05/2006 | EP1642969A1 Fluorescent protein and pigment protein |
| 04/05/2006 | EP1642968A2 Composition and methods for the diagnosis of tumours |
| 04/05/2006 | EP1642967A2 Composition and methods for the diagnosis of tumours |
| 04/05/2006 | EP1642910A1 Rationally designed antibodies |
| 04/05/2006 | EP1642909A2 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |